Opinion | March 24, 2022
Clinical Trials in the New Normal
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Company expects strong organic growth in sales, EBITDA in 2022
The products are based on a combination of mushrooms and cannabinoids that have achieved a strong therapeutic effect using low concentrations of THC. The treatment is expected to be launched in Israel, US and UK in H2 2022
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
Phase 2a clinical proof-of-concept biomarker study for PXL065 in ALD now anticipated to start midyear
According to Fortune Business Insights, the launch of new PCR-based detection techniques will lead to a surge in demand for PCR instruments in the coming years
Evonik invests in start-up to improve patient recovery after open-chest surgery
Resolv ER may remedy leading causes of blindness in adults
ICICI Direct’s analysis of Cipla’s Q3FY22 results
Subscribe To Our Newsletter & Stay Updated
